sirtris - 2/6 - Xconomy

Entry	Author	Date	Location
Vertex Co-Founder’s Hedge Fund RA Capital Makes Waves in Biotech Industry with Former Harvard Grad Student at Helm	Ryan McBride	11/03/08	Boston
Novartis Option Fund Managing Director Says First Responsibility is to Portfolio Companies, Dislikes “Corporate VC” Moniker	Ryan McBride	10/31/08	Boston
Sirtris Shifts Focus From Resveratrol, Merck Shifts People From Seattle to Boston, Epix Shifts Into Cost-Saving Mode, & More Boston-Area Life Sciences News	Rebecca Zacks	10/29/08	Boston
Sirtris’ Red Wine Chemical to Take Back Seat to “Potent” Diabetes Drugs	Ryan McBride	10/23/08	Boston
Biotech Luminaries Huddle at Boston R&D Conference, Mood “Surprisingly Optimistic”	Ryan McBride	10/23/08	Boston
Sirtris Settles in at GSK, Alnylam Raises IP Questions on Bio Bill, Targanta Takes on Cubist’s Market, & More Life Sciences News	Rebecca Zacks	09/24/08	Boston
Vertex Prices Stock Offering, $7M for Rapid7, Global Insight and NextPoint Acquired, & More Boston-Area Deals News	Rebecca Zacks	09/22/08	Boston
GI Dynamics Looks to Tackle Two Global Epidemics with Single Device, Reveals Seedling Roots	Ryan McBride	09/19/08	Boston
Sirtris’ Westphal Enjoying Life Under GSK Ownership; Hints at Positive Human Data on Next-Gen Drugs to Extend Healthy Life (and Still Partying on Fridays)	Ryan McBride	09/18/08	Boston
Millennium Enjoying New Era, Novartis Boosting Vaccine Effort, Living Proof Offering Frizz Fighters Online, & More Life Sciences News	Rebecca Zacks	09/17/08	Boston
Sirtris Gains SIRT3 Licenses from Harvard	Ryan McBride	09/16/08	Boston
Vertex Moves Hepatitis Drug Forward, Merrimack Rakes in $60M, Biogen and Icahn Trade Barbs, & More Life Sciences News	Rebecca Zacks	06/12/08	Boston
Long Courtship Preceded GlaxoSmithKline’s Sirtris Acquisition	Wade Roush	06/06/08	Boston
Heavyweight Hydrogen Takes $37 Million Prize for Concert Pharmaceuticals	Erik Mellgren	05/01/08	Boston
GSK Takes Sirtris and Taps Alnylam Venture, FDA Deals Genzyme Drug a Blow, Resolvyx Finances Fish-Oil Drugs, & More Life Sciences News	Rebecca Zacks	04/23/08	Boston
Sirtris Exec Says Acquisition by GlaxoSmithKline is “Great for Boston”	Wade Roush	04/22/08	Boston
GlaxoSmithKline Scoops Up Sirtris	Wade Roush	04/22/08	Boston
Barbara Walters to Feature Sirtris	Wade Roush	03/31/08	Boston
Sirtris Awarded Patent	Wade Roush	03/19/08	Boston
Sirtris Returns to Its “Roots” in Crop Deal with Bayer	Wade Roush	03/12/08	Boston
Sirtris Finds Anti-Cancer Effect, Teams with NIH	Wade Roush	02/22/08	Boston
Sirtris Anti-Aging Drug Generates Buzz, But May Already Be Old News	Wade Roush	01/08/08	Boston
Sirtris Touts Its Next Generation of Diabetes Drug Candidates, Massively More Powerful than its First	Wade Roush	11/28/07	Boston
Sir2 Roads Diverged: Elixir Co-founder Joins Rival Sirtris	Wade Roush	11/19/07	Boston
Page 2 of 2	« previous page

Entry

Author

Date

Location

Vertex Co-Founder’s Hedge Fund RA Capital Makes Waves in Biotech Industry with Former Harvard Grad Student at Helm

11/03/08

Novartis Option Fund Managing Director Says First Responsibility is to Portfolio Companies, Dislikes “Corporate VC” Moniker

Ryan McBride

10/31/08

Boston

Sirtris Shifts Focus From Resveratrol, Merck Shifts People From Seattle to Boston, Epix Shifts Into Cost-Saving Mode, & More Boston-Area Life Sciences News

Rebecca Zacks